Market Overview

Benzinga's Top Pre-Market Gainers

Related TRGT
Catalyst Biosciences Announces Positive Results From a Phase 1 Clinical Trial of Its Next Generation Coagulation Factor VIIa in Patients With Hemophilia A or B and Preclinical Results
Targacept and Catalyst Biosciences Amend Definitive Merger Agreement
Related VVUS
Neothetics' Fat Reduction Candidate Fails in Phase II Study
Why is Catalyst Pharmaceuticals' Stock Up 160% this Year?

Targacept (NASDAQ: TRGT) soared 5.34% to $4.54 in the pre-market trading. Targacept reported top-line results from a Phase 2 trial of TC-5619 in adults with inattentive-predominant attention deficit/hyperactivity disorder.

VIVUS (NASDAQ: VVUS) surged 3.58% to $23.75 in the pre-market session. VIVUS announced the US market availability of Qsymia™.

Vodafone Group Public Limited Company (NASDAQ: VOD) added 1.42% to $28.65 in the pre-market session. Vodafone has a dividend yield of 7%.

ARM Holdings plc (NASDAQ: ARMH) moved up 0.98% to $28.79 in the pre-market session. ARM Holdings' trailing-twelve-month operating margin is 36.82%.

Posted-In: Top Pre-Market GainersNews Pre-Market Outlook Markets Movers


Related Articles (ARMH + TRGT)

View Comments and Join the Discussion!

Partner Center